Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients

Author:

Okin Peter M.1,Devereux Richard B.1,Jern Sverker1,Kjeldsen Sverre E.1,Julius Stevo1,Dahlöf Björn1

Affiliation:

1. From the Department of Medicine, Division of Cardiology, Weill Medical College of Cornell University (P.M.O., R.B.D.), New York, NY; Sahlgrenska University Hospital/Östra (S.J., B.D.), Göteborg, Sweden; Ullevål University Hospital (S.E.K.), Oslo, Norway; and University of Michigan Medical Center (S.J.), Ann Arbor, Mich.

Abstract

Abstract —The Losartan Intervention For Endpoint (LIFE) reduction in hypertension study is a double-blind, prospective, parallel group study designed to compare the effects of losartan with those of atenolol on the reduction of cardiovascular morbidity and mortality. A total of 9194 patients with hypertension and ECG left ventricular hypertrophy (LVH) by Cornell voltage-duration product and/or Sokolow-Lyon voltage criteria were enrolled in the study, with baseline clinical and ECG data available in 8785 patients (54% women; mean age, 67±7 years). ECG LVH by Cornell voltage-duration product criteria was present in 5791 patients (65.9%) and by Sokolow-Lyon voltage in 2025 patients (23.1%). Compared with patients without ECG LVH by Cornell voltage-duration product criteria, patients with ECG LVH by this method were older; more obese; more likely to be female, white, and to have never smoked; more likely to be diabetic and have angina; and had slightly higher systolic, diastolic, and pulse blood pressures. In contrast, patients with ECG LVH by Sokolow-Lyon criteria were slightly younger; less obese; more likely to be male, black, and current smokers; less likely to have diabetes; more likely to have angina and a history of cerebrovascular disease; and had higher systolic and pulse blood pressure but slightly lower diastolic blood pressure than patients without ECG LVH by this method. By use of multivariate logistic regression analyses, presence of ECG LVH by Cornell voltage-duration product criteria was predominantly associated with higher body mass index, increased age, and female gender, whereas presence of ECG LVH by Sokolow-Lyon voltage criteria was predominantly related to lower body mass index, male gender, and black race. Thus, hypertensive patients who meet Cornell product and Sokolow-Lyon voltage criteria are associated with different, but potentially equally adverse, risk factor profiles.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference36 articles.

1. Dahlöf B Devereux R de Faire U Fyhrquist F Hedner T Ibsen H Julius S Kjeldsen S Kristianson K Lederballe-Pedersen O Lindholm LH Nieminen MS Omvik P Oparil S Wedel H for the LIFE Study Group. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension Study: rationale design and methods. Am J Hypertens . 1997;10(pt 1):705–713.

2. Apical wall stress by finite element analysis predicts subsequent left ventricular remodeling in the healing and early afterload reducing trial

3. Left Ventricular Hypertrophy by Electrocardiogram

4. Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3